Mill Creek Life Sciences announces receipt of a grant during the inaugural round of funding from Regenerative Medicine Minnesota.
News and Updates
Featured Article
Jun 18 2019
Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that supports the development and application of cellular and biological therapeutics, has received a one-year $100,000 grant from Regenerative Medicine Minnesota (RMM) titled: "Development of Technology for the Large-scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma."
May 30 2018
Written By
MN Cup
Mill Creek Life Sciences named a semifinalist in the 2018 MN Cup entrepreneurial competition.
Aug 22 2017
Written By
The Cell Culture Dish
Featured article from ISSCR 2017 on MSC NutriStem® Basal Medium (Biological Industries USA) and PLTMax® Human Platelet Lysate (Mill Creek Life Sciences)
Press Releases
Aug 18 2015
Sep 14 2011
With favorable regenerative and immunotolerant profiles, patient-derived human mesenchymal stem cells (hMSCs) are increasingly considered in cell therapy.
- Prev
- 2 of 2
Contact
Available from these distributors!
Research grade PLTMax® and PLTGold® are available from LAgen Laboratories in the 100mL bottle size.